462 related articles for article (PubMed ID: 3932474)
21. Characterization of the purified vitamin K-dependent gamma-glutamyl carboxylase.
Morris DP; Soute BA; Vermeer C; Stafford DW
J Biol Chem; 1993 Apr; 268(12):8735-42. PubMed ID: 8473318
[TBL] [Abstract][Full Text] [Related]
22. Recent findings in understanding the biological function of vitamin K.
Uotila L; Suttie JW
Med Biol; 1982 Feb; 60(1):16-24. PubMed ID: 6803084
[TBL] [Abstract][Full Text] [Related]
23. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
24. A comparison between vitamin K-dependent carboxylase from normal and warfarin-treated cows.
Vermeer C; Soute BA; De Metz M; Hemker HC
Biochim Biophys Acta; 1982 Feb; 714(2):361-5. PubMed ID: 6799008
[TBL] [Abstract][Full Text] [Related]
25. Studies in rats on in vitro inhibition and in vivo activity of vitamin-K-dependent carboxylation.
Cocchetto DM; Bjornsson TD
Haemostasis; 1986; 16(5):321-36. PubMed ID: 3781349
[TBL] [Abstract][Full Text] [Related]
26. Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition.
Preusch PC; Smalley DM
Free Radic Res Commun; 1990; 8(4-6):401-15. PubMed ID: 2113031
[TBL] [Abstract][Full Text] [Related]
27. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
Miyake N; Hoshi K; Sano Y; Kikuchi K; Tadano K; Koshihara Y
Osteoporos Int; 2001; 12(8):680-7. PubMed ID: 11580082
[TBL] [Abstract][Full Text] [Related]
28. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
Begent LA; Hill AP; Steventon GB; Hutt AJ; Pallister CJ; Cowell DC
J Pharm Pharmacol; 2001 Apr; 53(4):481-6. PubMed ID: 11341364
[TBL] [Abstract][Full Text] [Related]
29. Studies of the vitamin K-dependent carboxylase and vitamin K epoxide reductase in rat liver.
Suttie JW; Preusch PC
Haemostasis; 1986; 16(3-4):193-215. PubMed ID: 3530899
[TBL] [Abstract][Full Text] [Related]
30. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
Preusch PC; Suttie JW
Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
[TBL] [Abstract][Full Text] [Related]
31. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
Wallin R
Biochem J; 1986 Jun; 236(3):685-93. PubMed ID: 3098238
[TBL] [Abstract][Full Text] [Related]
32. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone.
Preusch PC; Suttie JW
Biochim Biophys Acta; 1984 Mar; 798(1):141-3. PubMed ID: 6704420
[TBL] [Abstract][Full Text] [Related]
33. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
[TBL] [Abstract][Full Text] [Related]
34. No strict coupling of vitamin K1 (2-methyl-3-phytyl-1,4-naphthoquinone)-dependent carboxylation and vitamin K1 epoxidation in detergent-solubilized microsomal fractions from rat liver.
Wallin R
Biochem J; 1979 Mar; 178(3):513-9. PubMed ID: 454361
[TBL] [Abstract][Full Text] [Related]
35. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
Wallin R; Wajih N; Hutson SM
Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197
[TBL] [Abstract][Full Text] [Related]
36. Temporal variation in the effects of warfarin on the vitamin K cycle.
Soulban G; Labrecque G; Bélanger PM
Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
[TBL] [Abstract][Full Text] [Related]
37. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
Lee JJ; Principe LM; Fasco MJ
Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the contribution of NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) to the reduction of vitamin K in wild-type and NQO1-deficient mice.
Ingram BO; Turbyfill JL; Bledsoe PJ; Jaiswal AK; Stafford DW
Biochem J; 2013 Nov; 456(1):47-54. PubMed ID: 24015818
[TBL] [Abstract][Full Text] [Related]
39. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
Uitendaal MP; Thijssen HH; Drittij-Reijnders MJ; Hoeijmakers MJ
Biochem Biophys Res Commun; 1986 Jun; 137(3):1015-20. PubMed ID: 3729947
[TBL] [Abstract][Full Text] [Related]
40. Comparative distribution, metabolism, and utilization of phylloquinone and menaquinone-9 in rat liver.
Reedstrom CK; Suttie JW
Proc Soc Exp Biol Med; 1995 Sep; 209(4):403-9. PubMed ID: 7638250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
